MARK2 and colorectal cancer: (Feng et al., 2020) revealed that TGM3 potentially suppressed cell proliferation through promoting apoptosis and cell cycle regulation and activating phosphorylated AKT serine/threonine kinase to inhibit invasion and metastasis in colorectal cancer cells (Feng et al., 2020).